Catherine C McGowan

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH
    Catherine C McGowan
    Division of Infectious Diseases, Department of Medicine, A 3310 Medical Center North, Vanderbilt University School of Medicine, Nashville, TN 37232 2605, USA
    Mol Microbiol 48:1225-39. 2003
  2. ncbi Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme
    Catherine C McGowan
    Vanderbilt University School of Medicine, Nashville, TN, USA
    Int J Epidemiol 36:969-76. 2007
  3. ncbi Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts
    Catherine C McGowan
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
    PLoS ONE 6:e18462. 2011
  4. ncbi The relationship between injection and noninjection drug use and HIV disease progression
    Han Zhu Qian
    Vanderbilt Institute for Global Health, Vanderbilt University School of Medicine, Nashville, TN, USA
    J Subst Abuse Treat 41:14-20. 2011
  5. ncbi Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
    C William Wester
    Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    AIDS 25:1471-9. 2011
  6. ncbi Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapy
    Bryan E Shepherd
    Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Epidemiology 21:698-705. 2010

Detail Information

Publications6

  1. ncbi Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH
    Catherine C McGowan
    Division of Infectious Diseases, Department of Medicine, A 3310 Medical Center North, Vanderbilt University School of Medicine, Nashville, TN 37232 2605, USA
    Mol Microbiol 48:1225-39. 2003
    ..pylori transcript abundance at acid pH. These studies document the complex response of H. pylori to environmental pH changes, and provide insight into mechanisms used for intragastric survival...
  2. ncbi Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme
    Catherine C McGowan
    Vanderbilt University School of Medicine, Nashville, TN, USA
    Int J Epidemiol 36:969-76. 2007
  3. ncbi Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts
    Catherine C McGowan
    Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America
    PLoS ONE 6:e18462. 2011
    ....
  4. ncbi The relationship between injection and noninjection drug use and HIV disease progression
    Han Zhu Qian
    Vanderbilt Institute for Global Health, Vanderbilt University School of Medicine, Nashville, TN, USA
    J Subst Abuse Treat 41:14-20. 2011
    ..Injection drug use is associated with poor HIV outcomes even among persons receiving highly active antiretroviral therapy (HAART), but there are limited data on the relationship between noninjection drug use and HIV disease progression...
  5. ncbi Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
    C William Wester
    Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    AIDS 25:1471-9. 2011
    ..To compare incidence and distribution of non-AIDS-defining events (NADEs) among HIV-1-infected adults receiving combination antiretroviral therapy (cART) in urban sub-Saharan African versus United States settings...
  6. ncbi Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapy
    Bryan E Shepherd
    Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Epidemiology 21:698-705. 2010
    ..We sought to expand this understanding using a novel statistical approach proposed by Robins et al...